Inhibiting GLS1 Attenuates Kidney Disease Induced Cardiac Hypertrophy in Male Mice
In preclinical mouse models, inhibiting glutaminase 1 attenuated chronic kidney disease–induced cardiac hypertrophy driven by metabolic reprogramming and mitochondrial dysfunction.










